| Literature DB >> 24642130 |
Sophie Githinji1, Samwel Kigen, Dorothy Memusi, Andrew Nyandigisi, Andrew Wamari, Alex Muturi, George Jagoe, René Ziegler, Robert W Snow, Dejan Zurovac.
Abstract
BACKGROUND: Effective surveillance systems are required to track malaria testing and treatment practices. A 26-week study "SMS for Life" was piloted in five rural districts of Kenya to examine whether SMS reported surveillance data could ensure real-time visibility of accurate data and their use by district managers to impact on malaria case-management.Entities:
Mesh:
Year: 2014 PMID: 24642130 PMCID: PMC3995152 DOI: 10.1186/1475-2875-13-107
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1Screenshots of web-based surveillance reporting tool (A) surveillance data dashboard; (B) Display of health facilities surveillance report for one week in one study district.
Figure 2Proportion of health facilities that responded to surveillance data request messages and SMS formatting errors by week. Black bars show responses within 0–24 hrs; dark grey bars responses within 24–27 hrs (after reminder but within incentive period); light grey bars responses within 27 hrs-7 days (after the incentive period); white bars shows no responses, and black line shows SMS formatting errors.
Figure 3Accuracy of SMS reported surveillance parameters. Black bars show correctly reported surveillance reports (± 0-10%); dark grey bars show counts with discrepancy ± 10-20%; light grey bars show counts with discrepancy ± 20-30%, and white bars show counts with >30% discrepancy.
Figure 4Testing rates, test positivity rates and ratio of anti-malarial treatments to test positives overall and by district during the 26 weeks follow-up period. (A) Overall testing rates, test positivity rates and ratio of anti-malarial treatments to test positives; (B) Testing rates, test positivity rates and ratio of anti-malarial treatments to test positives for Machakos Distict; (C) Testing rates, test positivity rates and ratio of anti-malarial treatments to test positives for Msambweni district; (D) Testing rates, test positivity rates and ratio of anti-malarial treatments to test positives for Ijara district; (E) Testing rates, test positivity rates and ratio of anti-malarial treatments to test positives for Manga district; (F) Testing rates, test positivity rates and ratio of anti-malarial treatments to test positives for Vihiga district.